XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 1,157,080 $ 884,377
Investments held in marketable securities 15,261,220 10,181,618
Accounts receivable 35,000 19,300
Prepaid expenses and other current assets 316,963 305,231
Total Current Assets 16,770,263 11,390,526
Property and equipment, net 365,025 356,055
Right-of-use assets 115,385 151,447
Intangible assets, net 691,255 713,692
Deferred offering costs 9,538
Total Assets 17,951,466 12,611,720
Current Liabilities:    
Accounts payable 230,902 189,389
Accrued expenses and other current liabilities 338,343 711,686
Lease liability 123,536 162,317
Derivative liabilities 2,755,358 1,543,953
Total Current Liabilities 3,448,139 2,607,345
Total Liabilities 3,448,139 2,607,345
Commitments and contingencies
Stockholders’ Equity:    
Common stock, $0.0001 par value; 75,000,000 shares authorized; 6,769,919 and 4,706,917 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively 677 471
Additional paid-in capital 163,411,257 156,689,256
Accumulated deficit (148,922,589) (146,699,334)
Total Stockholders’ Equity 14,503,327 10,004,375
Total Liabilities and Stockholders’ Equity 17,951,466 12,611,720
Series B Convertible Preferred Stock [Member]    
Stockholders’ Equity:    
Preferred Stock, value $ 13,982 $ 13,982